Three Drugs Added to Knowledgebase

We recently added 3 new drugs to the knowledgebase:
 

• Dazodalibep a CD40 ligand antagonist for the treatment of Sjögren’s syndrome and rheumatoid arthritis is being developed by Horizon Therapeutics
• RRx-001 an NLRP3 inhibitor for the treatment oral mucositis in patients receiving radiation and chemotherapy for head and neck cancer is being developed by EpicentRx
• Bexagliflozin an SGLT-2 for the treatment of type 2 diabetes is being developed by TheracosBio

 
The Prescribe Right Pharmaceutical Pipeline Tracker now allows you to track 1,113 pipeline and recently approved drugs supported by 2,952 announced and published study results.